Gentamicin for Horses: Uses, Side Effects & Status in Competition

Gentamicin for horses is a prescription antibiotic used to help manage certain bacterial infections, particularly those involving gram-negative bacteria.

Gentamicin is an important treatment option in cases of serious equine infections, and must be used carefully. The correct route, dose, duration, and monitoring plan depend on the horse’s age, hydration status, kidney function, infection site, culture results, and other medications being used.

Horse owners should understand that gentamicin is not appropriate for every infection and is not effective against viruses, fungi, or many anaerobic bacteria. Improper use can increase the risk of treatment failure, kidney injury, adverse drug interactions, and antimicrobial resistance.

Keep reading to learn how gentamicin works in horses, when veterinarians may use it, how it is administered, what safety precautions apply, and why veterinary oversight is essential throughout treatment.

Gentamicin for Horses

Gentamicin sulfate is a bactericidal antibiotic in the aminoglycoside class. Bactericidal means the drug kills target bacteria rather than only slowing their growth. ^[1]

Gentamicin is concentration-dependent, which means it must reach an established minimum inhibitory concentration (MIC) in the body to work effectively. To measure effectiveness during treatment, veterinarians can compare the drug level in the horse’s blood to the MIC and adjust dosages accordingly. ^[1][2]

Gentamicin is most useful against aerobic gram-negative bacteria, including: ^[1]

• E. coli
• Klebsiella spp.
• Proteus spp.
• Pseudomonas spp.
• Salmonella spp.
• Enterobacter spp.
• Serratia spp.

It may also have activity against some Staphylococcus species. It is not effective against viruses, fungi, or most anaerobic bacteria. ^[1]

Available Forms

Gentamicin is available in injectable formulations, including veterinary-labelled gentamicin sulfate products. Human-labelled injectable, topical, ophthalmic (eye), and otic (ear) formulations are also available in some jurisdictions. ^[1]

Brand and other names for gentamicin include: ^[1]

• Gentamicin sulfate
• Gentamicin sulphate
• Gentocin^®
• Garamycin^®
• Gentamax^®
• Gentafuse^®
• Gentaved^®
• Gentozen^®

×

Enjoy $10 Off From Us

What's your top priority with your horse's health?

🦴 Joint Health 🐎 Hoof Health 💪 Topline & Muscles 🥕 Gut Health & Digestion 🏆 Athletic Performance ⚡ Metabolic Health 🌿 Behavior & Calming 💨 Respiratory Health

• Yes, send me expert advice on horse health and nutrition

* Limit one per customer

Drug Class: Aminoglycoside Antibiotics

Aminoglycosides are antibiotics used mainly for serious infections caused by aerobic gram-negative bacteria. These drugs are often reserved for situations where culture results, disease severity, or the suspected bacteria justify use despite the potential for kidney toxicity. ^[1]

Other aminoglycoside antibiotics used in veterinary medicine include: ^[1]

• Amikacin
• Neomycin
• Kanamycin
• Streptomycin
• Tobramycin

Because aminoglycosides are poorly absorbed from the gastrointestinal tract, they are generally administered by injection when systemic treatment is required.

After injection, aminoglycosides distribute primarily into extracellular fluid and are removed from the body mainly by the kidneys.
^[1]

Mechanism of Action

Gentamicin acts by disrupting ribosome activity in bacteria cells. This prevents the bacteria from producing essential proteins they need to survive. ^[1]

Gentamicin’s effect is concentration-dependent, which means it must reach a minimum inhibitory concentration (MIC) in the blood to work. The MIC for concentration-dependent drugs varies across bacterial species, which underscores the importance of veterinary oversight when administering antibiotics.

Veterinarians may use ongoing drug monitoring during treatment to compare blood gentamicin concentrations with target ranges and the MIC of the bacteria being treated. ^[2][3]

Gentamicin also has a post-antibiotic effect, meaning bacterial growth may remain suppressed even after blood drug concentrations fall below the MIC. This is one reason many modern aminoglycoside protocols use extended-interval dosing under veterinary supervision rather than frequent smaller doses. ^[1][4]

Uses in Horses

Gentamicin is used in horses for infections where aerobic gram-negative bacteria are suspected or confirmed, especially when rapid systemic antibiotic coverage is needed. It may be used alone for selected bacteria, but is commonly combined with another antibiotic to broaden coverage. ^[1][2]

Approved uses vary by country, formulation, and product label. In some jurisdictions, equine-labelled gentamicin products are approved for specific routes or indications, such as intrauterine use or certain injectable applications. ^[1] In North America, there are only intrauterine formulations approved for equine use currently.

There are also situations where veterinarians may prescribe gentamicin for uses not specifically indicated on the product label. These uses are referred to as “off-label” or “extra-label.” Off-label use is permitted under veterinary prescribing regulations, and is performed at the discretion of the treating veterinarian. Most use cases of gentamicin in North America are off-label, as only intrauterine formulations are currently approved for horses.

Antibiotic Spectrum

Gentamicin has a narrower spectrum than many other antibiotics, meaning it is effective against a more limited range of bacteria.

Its main activity is against aerobic gram-negative bacteria, although it may also be effective against some aerobic gram-positive bacteria. ^[1]

Veterinarians may consider gentamicin when they suspect or confirm infections caused by bacteria such as: ^[1][2]

• Escherichia coli
• Klebsiella spp.
• Proteus spp.
• Pseudomonas spp.
• Salmonella spp.
• Enterobacter spp.
• Serratia spp.
• Certain Staphylococcus species

Gentamicin is not effective against viruses, fungi, or most anaerobic bacteria. It may also be less effective when the target bacteria are resistant, when the infection site is difficult for the drug to penetrate, or when local conditions are unfavorable for aminoglycoside activity. ^[1]

Equine studies show that gentamicin may work better against bacteria from some settings than others. In one study, about 90% of bacterial samples from horses treated outside of a hospital setting were vulnerable to gentamicin. In contrast, only about 40% of samples from hospital cases responded to gentamicin. ^[2]

Another study in hospitalized horses also found high resistance among gram-negative bacteria. ^[3] These findings show why veterinarians consider the horse’s setting, local resistance patterns, and culture results before choosing gentamicin.

On-Label Uses

Gentamicin is currently only labelled for intrauterine use in horses in North America. This treatment involves directly infusing the uterus with the antibiotic diluted in saline solution. This helps treat uterine infections and improves conception rates in mares with uterine infections. ^[1][2][3]

Off-Label Uses

Off-label uses of gentamicin in horses commonly involve systemic injectable treatment for: ^[1][2][3]

• Sepsis
• Postoperative antimicrobial prophylaxis (preventive antibiotic use)
• Pneumonia
• Peritonitis
• Wounds
• Urinary infections
• Ocular infections
• Abscesses

Gentamicin is not a substitute for diagnosis, source control, surgery, drainage, wound care, supportive care, or antimicrobial stewardship. Whenever possible, veterinarians use culture and susceptibility testing to confirm whether gentamicin is likely to work against the bacteria involved. ^[2][3]

Administration Routes

Gentamicin is a prescription antibiotic. Dosing, route, frequency, duration, culture testing, and monitoring must be determined by a licensed veterinarian based on the type of infection, kidney function, hydration status, age, concurrent medications, and local resistance patterns.

Gentamicin may be administered intravenously, intramuscularly, directly intrauterine, topically, ophthalmically, or by other local routes depending on the formulation and condition being treated. Systemic injectable use is generally handled by a veterinarian or trained veterinary staff. ^[1]

Therapeutic drug monitoring may be recommended, especially in hospitalized horses, foals, horses with abnormal kidney values, horses receiving repeated doses, or cases where resistant bacteria are a concern. Monitoring commonly focuses on peak concentrations, trough concentrations, kidney values, urinalysis, hydration, and clinical response. ^[1][2][3]

In one large equine practice study, a common gentamicin protocol produced blood concentrations expected to be effective against many bacteria from ambulatory practice, but was less likely to be effective against resistant hospital-derived isolates.

Another hospitalized-horse study found that individual drug monitoring was important because clinical factors did not reliably predict which horses would reach target concentrations. ^[2][3]

Dosage

For intrauterine use, the label dose is 2 – 2.5 g of gentamicin diluted in 200 – 500 mL of sterile saline given once daily. ^[1] Aseptic technique is necessary for intrauterine use and should only be performed by a veterinarian or trained veterinary team member.

Dosing for off-label equine injectable gentamicin use varies significantly depending on the horse’s age, condition, and type of infection. ^[1]

Storage

Store gentamicin according to the manufacturer’s label. Veterinary references generally describe injectable and oral solution products as being stored at room temperature, with freezing and excessive heat avoided. ^[1]

Do not mix gentamicin with other medications in the same syringe, fluid bag, or line unless directed by a veterinarian or pharmacist. Gentamicin can be physically or chemically incompatible with some drugs, and beta-lactam antibiotics can inactivate aminoglycosides. ^[1]

Safety Warnings & Precautions

Gentamicin should be used only when a veterinarian determines that the likely benefit outweighs the risk. Culture and susceptibility testing are especially important because gentamicin resistance can be common in hospital-derived bacteria, and simply increasing the dose may not overcome resistant organisms. ^[2][3]

Hydration and kidney function are critical safety considerations. Dehydration, shock, fever, sepsis, kidney disease, and concurrent nephrotoxic drugs can increase the risk of gentamicin-associated kidney injury. ^[1][4]

Pregnancy and lactation require veterinary risk-benefit assessment. Aminoglycosides can cross the placenta and may rarely cause fetal kidney or cranial nerve toxicity. Small amounts may pass into milk, although risk to nursing offspring is considered minimal in veterinary references. ^[1]

Monitoring

Horses receiving systemic gentamicin may be monitored for:

• Temperature, attitude, appetite, pain, and other signs of infection
• Culture and susceptibility results when samples are available
• Hydration status and fluid balance
• Serum creatinine, blood urea nitrogen, and other kidney markers
• Urinalysis, including urine sediment and casts
• Gentamicin blood concentrations when therapeutic drug monitoring is available
• Signs of vestibular, auditory, or neuromuscular toxicity

Veterinarians may check gentamicin levels in the blood to make sure the dose is safe and effective. The lowest level reached before the next dose, called the trough level, helps show whether the drug is clearing from the body, which helps determine if there is a higher risk of toxicity before giving the next dose.

The highest level after dosing, called the peak level, helps show whether the drug reached a strong enough concentration to fight the bacteria. ^[1][2][3]

Antibiotic Resistance

Antibiotic resistance occurs when bacteria adapt in ways that make antibiotics less effective. This can happen naturally, but inappropriate antibiotic use can speed up the process. When resistant bacteria survive treatment, they can multiply and spread, making future infections harder to treat.

This is a serious concern for individual horses and for the wider equine population. If gentamicin is used when it is not needed, given at the wrong dose, stopped too early, or used against bacteria that are already resistant, the infection may not respond. The horse may then need additional testing, longer treatment, different medications, or more intensive veterinary care.

Resistance can also affect more than one horse. Resistant bacteria may spread between animals through direct contact, shared equipment, contaminated environments, wounds, manure, or hospital settings. Some resistant bacteria can also affect other species, including people, which is why antibiotic use in horses is part of a broader public health issue.

Veterinarians reduce this risk by choosing antibiotics carefully. When possible, they use culture and susceptibility testing to identify the bacteria involved and determine which antibiotics are most likely to work. They also consider the infection site, severity of illness, local resistance patterns, previous antibiotic exposure, and the horse’s kidney function before selecting gentamicin.

Contraindications

Contraindications refer to circumstances where a drug should be avoided or used with caution.

Gentamicin is contraindicated in horses with known hypersensitivity to gentamicin or other aminoglycosides. It should be used with extreme caution in horses with pre-existing: ^[1]

• Renal dysfunction
• Dehydration
• Sepsis
• Fever
• Shock
• Risk of kidney disease

Caution is also warranted in neonatal foals, geriatric horses, and in those receiving other nephrotoxic medications, as both young and older animals may have altered drug handling, and renal clearance can be significantly reduced in sick or dehydrated patients. ^[1][3]

Gentamicin should be used carefully in horses with neuromuscular disorders, as it may potentiate neuromuscular blockade, especially in the presence of neuromuscular-blocking agents and certain anesthetics.

Additionally, concurrent use with drugs such as general anesthetics, neuromuscular blocking agents, or other medications that can depress neuromuscular transmission (e.g., magnesium sulfate, organophosphates) increases the risk of profound neuromuscular blockade. ^[1][4]

Administration with specific drugs increases the risk or severity of kidney or ear issues, including: ^[1]

• Nonsteroidal anti-inflammatory drugs (NSAIDs)
• Amphotericin B
• Cisplatin
• Polymyxin B
• Vancomycin
• Furosemide (Lasix)
• Mannitol

Direct mixing of gentamicin with beta-lactam antibiotics (such as penicillins or cephalosporins) should be avoided due to potential inactivation of gentamicin. ^[1]

Side Effects

Gentamicin and other aminoglycosides are associated with nephrotoxicity (kidney injury), ototoxicity (inner ear toxicity affecting hearing and balance), and neuromuscular blockade. ^[1]

The risk of side effects is highly influenced by patient factors including: ^[1][4]

• Underlying health status
• Renal function
• Hydration
• Age
• Sepsis or shock
• Concurrent illness
• Treatment duration
• Dose
• Use of other medications, especially nephrotoxic or ototoxic drugs

Potential side effects include: ^[1][4]

• Kidney toxicity: Increased serum creatinine and blood urea nitrogen may occur. Acute tubular necrosis is possible with overdose or in at-risk animals.
• Urinary abnormalities: Proteinuria, urinary casts, or other urinary abnormalities may develop.
• Changes in urination: Loss of urine-concentrating ability, polyuria (high urine volume), or changes in the frequency or appearance of urination may occur.
• Ototoxicity: Damage to the inner ear that may impair hearing, balance, or coordination.
• Vestibular dysfunction: Signs may include head tilt, ataxia, nystagmus (uncontrolled eye movements), or circling.
• Neuromuscular blockade: Muscle weakness, recumbency, or possible respiratory distress may occur.
• Injection-site reaction: Pain or localized tissue irritation may occur at the injection site.
• Allergic reaction: Hypersensitivity or other allergic-type reactions are possible.

Kidney effects are a leading safety concern because gentamicin can accumulate in the cells of the kidney tubules, where it may cause low-grade damage even when used for a short period.

Some studies in hydrated ponies and foals found reversible kidney changes after treatment, but these horses did not develop obvious clinical kidney injury. However, sick horses are at higher risk, especially if they are dehydrated, septic, or already have reduced kidney function. ^[1][4]

Acute Toxicity (Overdose)

Gentamicin toxicity can result from overdose, inappropriate dosing intervals, excessive drug accumulation, or drug interactions.

Signs of gentamicin overdose include: ^[1]

• Acute kidney injury
• Vestibular or cochlear signs (ataxia, head tilt, hearing loss)
• Neuromuscular paralysis
• Colic
• Muscle trembling
• Lethargy
• Reduced or absent urination

Drug Interactions

Gentamicin has a clinically significant interaction profile. Disclose all prescription and non-prescription drugs, supplements, recent treatments, and anesthetic agents to your veterinarian before starting your horse on gentamicin. ^[1]

Key interactions include: ^[1]

• Beta-lactam antibiotics (penicillins, cephalosporins): May improve outcomes if administered separately, but these drugs are physically incompatible with gentamicin. Do not mix in the same syringe or infusion bag as gentamicin, as beta-lactams can inactivate aminoglycosides.
• Cephalosporins: Some cephalosporins have been implicated in increased kidney damage when administered with gentamicin.
• Loop diuretics (furosemide) and osmotic diuretics (mannitol): Can increase the risk of nephro- and ototoxicity.
• Other nephrotoxic/ototoxic agents: Additive risk for renal and auditory injury. Potential interactions include amphotericin B, cisplatin, polymyxin B, and vancomycin.
• General anesthetics and neuromuscular-blocking drugs: Heightened risk of neuromuscular blockade and respiratory paralysis; caution and careful monitoring required during anesthesia or in horses with neuromuscular disorders.
• Magnesium sulfate, organophosphates: May create favorable conditions for neuromuscular blockade, especially in combination with gentamicin.

Additionally, laboratory/test sample handling can introduce errors. Gentamicin levels measured in serum samples may be artifactually decreased if the sample is contaminated by (or drawn during elevated levels of) beta-lactam antibiotics and not frozen immediately.

This is why veterinarians draw monitoring samples when beta-lactam concentrations are lowest (trough). ^[1]

Regulatory Status and Legal Considerations

Gentamicin is a prescription antibiotic in many jurisdictions. Veterinary-labelled products and approved uses vary by country, species, route, and formulation. In horses, some uses may be approved while others are off-label and must follow local veterinary prescribing rules. ^[1]

Antibiotic stewardship is an important legal and ethical consideration. Gentamicin should not be used casually, as a single “just in case” treatment, or without veterinary assessment. Unnecessary or poorly targeted antibiotic use can contribute to treatment failure and antimicrobial resistance.

Status in Competition

Gentamicin is not listed as a banned substance or controlled medication on the FEI Equine Prohibited Substances List. ^[5]

This means gentamicin is not banned, but use during an FEI event is conditional on event medication rules. FEI Veterinary Form B is used for medication and supportive therapies that are not included on the list, including antibiotics, when they need to be monitored during events. Treatment must follow FEI event medication rules and be completed by an FEI Permitted Treating Veterinarian when required. ^[6]

The FEI List of Detection Times does not provide a detection time for gentamicin. Detection times are not the same as withdrawal times; withdrawal time must be determined by the treating veterinarian with an appropriate safety margin based on the horse, product, dose, route, timing, and health status. ^[7]

Always check current rules for your specific sport, federation, and jurisdiction before giving any medication to a competition horse. A horse requiring systemic antibiotics may not be healthy or fit to compete, even if the drug itself is not listed as prohibited.

Frequently Asked Questions

Here are some frequently asked questions about gentamicin for horses:

Summary

Gentamicin is a prescription aminoglycoside antibiotic used in horses for certain bacterial infections, particularly those involving aerobic gram-negative bacteria. Because it can cause kidney, ear, and neuromuscular toxicity, it must be used only under veterinary direction with appropriate dosing, monitoring, and stewardship.

• Gentamicin is most useful against aerobic gram-negative bacteria and is not effective against viruses, fungi, or most anaerobic bacteria
• Veterinarians may use gentamicin for selected infections depending on the culture results and local resistance patterns
• Dose, route, frequency, duration, and monitoring must be determined by a licensed veterinarian based on the horse and infection
• Hydration, kidney function, age, illness severity, and concurrent medications strongly influence the risk of side effects
• Culture and susceptibility testing help determine whether gentamicin is likely to work and support responsible antibiotic use
• Competition horses treated with gentamicin must follow current medication rules for their sport, event, and jurisdiction